Prime Therapeutics: Processing Update for Generic Relpax® for Commercial Covered Persons

Effective December 26th 2016

Author: Kailee Burnett/Wednesday, December 28, 2016/Categories: APCI Choice

Dear Valued Provider,

On December 26th, 2016, generic Relpax (eletriptan) will become available to the market. Please see the client specific attachments below for further processing instructions.


If you have any questions about claims processing, please call the Prime Contact Center at 800.821.4795.  

Sincerely,
Pharmacy Network Management
Prime Therapeutics LLC

Prime Therapeutics Contracting Fax number: 877-823-6373

*Please see attached PDF for more information.

Comments are only visible to subscribers.